HRI has released a new infographic featuring recent findings from a study shedding light on the process of recovery from mental illness and addiction.Read More “Infographic: new findings from study exploring long-term recovery from addiction”
HRI is the proud recipient of $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations, including people requiring treatment for mental illness and substance use disorder (SUD).Read More “HRI awarded $100K from CCSA, Health Canada to explore impacts of cannabis legalization”
In our latest Research Snapshot, we profile findings about improvements to screening tools that may help to identify concurrent mental health conditions in people requiring treatment for addiction.Read More “New findings focus on screening tools that can improve addiction treatment and planning”
HRI Senior Scientist, Dr. James MacKillop, has received $491,000 from the Canadian Institutes of Health Research (CIHR) for a study that will examine the impact of COVID-19 on mental health and substance use.Read More “New funding will support research exploring impact of COVID-19 on mental health”
Treatment of alcohol use disorder is multi-faceted and often includes participation in mutual-support groups, the oldest and largest of which is Alcoholics Anonymous (AA).
Although frequent AA meeting attendance is associated with greater abstinence from alcohol, there is little understanding of the specific mechanisms by which AA benefits people. In other words, we know that AA works, but we aren’t sure how.Read More “International study explores how AA contributes to recovery”
The CBD industry is booming. CBD (short for cannabidiol) is a chemical compound derived from the cannabis plant that is marketed as a cure-all and added to everything from bath bombs to dog treats.
But has the hype of CBD gotten ahead of the science?Read More “Exploring the use of CBD in treating alcohol use disorder”
As Canada enters its second month following the nationwide legalization of cannabis, Dr. James MacKillop, HRI Senior Scientist and Director of the Peter Boris Centre for Addictions Research and the Michael G. DeGroote Centre for Medicinal Cannabis Research, is encouraging Canadians to think critically about cannabis use.Read More “HRI Senior Scientist contributes to national discussions on the legalization of cannabis”
Military members and veterans are among those most vulnerable to post-traumatic stress disorder (PTSD). There is an urgent need to identify new and innovative treatments that will help military members suffering from trauma-related illnesses.Read More “Advancing research for military and veteran mental health”
Addiction and post-traumatic stress disorder (PTSD) often occur together, causing debilitating consequences for those affected. There is little consensus among clinicians about how best to treat individuals suffering from both disorders, but new research is providing hope for patients and healthcare providers alike. This will be the focus of an upcoming symposium.Read More “Upcoming symposium on addiction and PTSD”
Recovery from addiction can mean different things to different people. A recent publication by HRI Research and Evaluation Scientist, Dr. Jean Costello, highlights the importance of incorporating insights from people with lived experience when building systems for measuring treatment success.Read More “Promoting patient-oriented research”